AXS Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AXS Investments's ELV Position: Q2 2026 in Review
AXS Investments reduced its Elevance Health (ELV) stake by 20% in Q2 2026, selling an estimated $37.1K and leaving 400 shares worth $155K. The position accounts for 0.04% of the portfolio, ranked #125.
AXS Investments first reported a position in ELV in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.1M in Q1 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- AXS Investments held 400 shares of Elevance Health worth $155K as of Q2 2026.
- AXS Investments sold 100 Elevance Health shares in Q2 2026, an estimated $37.1K.
- Elevance Health made up 0.04% of AXS Investments's portfolio in Q2 2026, its #125 holding.
- AXS Investments first reported a position in Elevance Health in Q1 2021 and has held it in 20 quarters since.
- AXS Investments's Elevance Health position peaked at $1.1M in Q1 2021.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.